valproic acid and gw9662

valproic acid has been researched along with gw9662 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Angelucci, A; Bologna, M; Cerù, MP; Cimini, A; Cristiano, L; Dolo, V; Miano, R; Millimaggi, D; Muzi, P; Vicentini, C	1

Other Studies

1 other study(ies) available for valproic acid and gw9662

Article	Year
Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma. The Prostate, 2008, May-01, Volume: 68, Issue:6 Topics: Adenocarcinoma; Anilides; Animals; Cell Line, Tumor; Cell Proliferation; Cell Transdifferentiation; Cell Transformation, Neoplastic; Drug Combinations; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Male; Mice; Mice, Nude; Neurosecretory Systems; PPAR gamma; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Valproic Acid; Xenograft Model Antitumor Assays	2008

Article

Year

Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma.

The Prostate, 2008, May-01, Volume: 68, Issue:6

Topics: Adenocarcinoma; Anilides; Animals; Cell Line, Tumor; Cell Proliferation; Cell Transdifferentiation; Cell Transformation, Neoplastic; Drug Combinations; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Male; Mice; Mice, Nude; Neurosecretory Systems; PPAR gamma; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Valproic Acid; Xenograft Model Antitumor Assays

2008